STAT5A and TLR9, both of which interact with BTK, a functionally relevant target downstream of FLT3-ITD were hypermethylation in FLT3-ITD vs. non FLT3-ITD AML cases. The gene discussed is STAT5A; the disease is acute myeloid leukemia.